Clinical Trial Update: Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for intraoperative hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer completed across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Epithelial Ovarian Cancer | Phase 2, Phase 3 | Status: COMPLETED